Interactions of Alzheimers B-Amyloid with Lipid Membranes
About the Research Project
Program
Award Type
Standard
Award Amount
$198,570
Active Dates
April 01, 1999 - March 31, 2000
Grant ID
A1999057
Summary
Increasing evidence has suggested that the fibril form of Alzheimer’s beta-amyloid (Ab) is neurotoxic in Alzheimer’s disease, and in vitro evidence has suggested that Ab fibrils can be formed at very low peptide concentrations if membrane lipids are present. Dr. Lee’s long-range goal is to understand the role of membrane lipids in Ab neurotoxicity. She is screening Ab peptides (Ab-140 and Ab-142) for specific interactions with a variety of individual membrane lipids and with lipid mixtures. After the initial screening, she will use a combination of optical and physical techniques to further characterize the association of Ab peptides with lipids and the effects of the peptides on lipid membranes. She will also characterize fibril formation and obtain high resolution images with atomic force microscopy. Dr. Lee’s investigation is one of two studies funded by the Irwin Lee Challenge Grant.
Grants
Related Grants
Alzheimer's Disease Research
Partnership with Molecular Neurodegeneration Open Access Journal
Active Dates
July 01, 2010 - June 30, 2015
Principal Investigator
Guojun Bu, PhD
Partnership with Molecular Neurodegeneration Open Access Journal
Active Dates
July 01, 2010 - June 30, 2015
Principal Investigator
Guojun Bu, PhD
Alzheimer's Disease Research
Identifying Women-Specific and Men-Specific Risk Factors for Alzheimer’s Disease
Active Dates
July 01, 2022 - June 30, 2024
Principal Investigator
Gael Chetelat, PhD
Identifying Women-Specific and Men-Specific Risk Factors for Alzheimer’s Disease
Active Dates
July 01, 2022 - June 30, 2024
Principal Investigator
Gael Chetelat, PhD
Alzheimer's Disease Research
Mitochondrial Prodrug to Treat Repeated Mild Traumatic Brain Injury
Active Dates
September 08, 2021 - December 31, 2023
Principal Investigator
Patrick Sullivan, PhD
Mitochondrial Prodrug to Treat Repeated Mild Traumatic Brain Injury
Active Dates
September 08, 2021 - December 31, 2023
Principal Investigator
Patrick Sullivan, PhD